Tom Wilkinson
Overview
Explore the profile of Tom Wilkinson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
1880
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wilkinson T, Meier R, Hewapathirana N, Lever C, Donnelly S, Sampson R, et al.
Diabetes Technol Ther
. 2025 Jan;
PMID: 39869185
This study evaluated a next-generation automated insulin delivery (AID) algorithm for Omnipod in type 1 and type 2 diabetes across multiple phases: 14-day run-in with usual therapy, 48-h AID use...
2.
Freeman A, Minnion M, Lee P, Haitchi H, Kurukulaaratchy R, Wilkinson T, et al.
Allergy
. 2024 Dec;
PMID: 39698749
No abstract available.
3.
IL-33 is associated with alveolar dysfunction in patients with viral lower respiratory tract disease
Scott I, Van Zuydam N, Cann J, Negri V, Tsafou K, Killick H, et al.
Mucosal Immunol
. 2024 Dec;
PMID: 39662674
Interleukin (IL)-33 is released following tissue damage, causing airway inflammation and remodelling via reduced IL-33 (IL-33)/serum stimulation-2 (ST2) and oxidised IL-33 (IL-33)/receptor for advanced glycation end products (RAGE)/epidermal growth factor...
4.
MacIntyre C, Correia de Sousa J, Heininger U, Kardos P, Konstantopoulos A, Middleton D, et al.
Hum Vaccin Immunother
. 2024 Jul;
20(1):2377904.
PMID: 39016172
A panel of 24 international experts met in July 2022 to discuss challenges associated with pertussis detection, monitoring, and vaccination in adults; conclusions from this meeting are presented. There has...
5.
Breisnes H, Leeming D, Karsdal M, Burke H, Freeman A, Wilkinson T, et al.
BMC Pulm Med
. 2024 Jul;
24(1):331.
PMID: 38982423
Background: Coronavirus disease 2019 (COVID-19) is a viral pneumonia that can result in serious respiratory illness. It is associated with extensive systemic inflammation, changes to the lung extracellular matrix, and...
6.
Kardos P, Correia de Sousa J, Heininger U, Konstantopoulos A, MacIntyre C, Middleton D, et al.
Hum Vaccin Immunother
. 2024 Apr;
20(1):2324547.
PMID: 38564339
Pertussis has several notable consequences, causing economic burden, increased strain on healthcare facilities, and reductions in quality of life. Recent years have seen a trend toward an increase in pertussis...
7.
Wilkinson T, Tomic D, Boyle E, Burren D, Elghattis Y, Jenkins A, et al.
BMJ Open
. 2024 Feb;
14(2):e078171.
PMID: 38382954
Introduction: Multiple automated insulin delivery (AID) systems have become commercially available following randomised controlled trials demonstrating benefits in people with type 1 diabetes (T1D). However, their real-world utility may be...
8.
Ritchie A, Donaldson G, Hoffman E, Allinson J, Bloom C, Bolton C, et al.
Am J Respir Crit Care Med
. 2024 Jan;
209(10):1208-1218.
PMID: 38175920
Chronic obstructive pulmonary disease (COPD) due to tobacco smoking commonly presents when extensive lung damage has occurred. We hypothesized that structural change would be detected early in the natural history...
9.
Wilkinson T, Hunt P, McHaffie A
JCEM Case Rep
. 2023 Nov;
1(1):luac029.
PMID: 37908270
The presence of macroscopic fat on computed tomography (CT) imaging has been traditionally regarded as an indication that an adrenal lesion is likely to be a benign myelolipoma, for which...
10.
Wilkinson T, Soyza A, Carroll M, Chalmers J, Crooks M, Griffiths G, et al.
ERJ Open Res
. 2023 Oct;
9(5).
PMID: 37868151
Background: Increased serum interleukin (IL)-33 predicts poor outcomes in patients hospitalised with coronavirus disease 2019 (COVID-19). We examined the efficacy and safety of tozorakimab, a monoclonal antibody that neutralises IL-33,...